Abstract
The diagnostic and prognostic significance of cutaneous affection in COVID-19 remains unclear. Some of the reported skin manifestations including erythema multiforme were considered associated cutaneous adverse drug reactions. Furthermore, it was suggested that erythema multiforme can be associated with good prognosis for COVID-19 infection. This case report, likewise, describes a patient with mild symptoms of COVID-19, presenting with localized erythema multiforme-like lesions of the palms. The skin lesions appeared before receiving any medications. This supports that erythema multiforme can be a cutaneous presentation of COVID-19, rather than a drug eruption.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the Egyptian Women's Dermatologic Society
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
